PULMATRIX, INC. Operating Expenses
PULMATRIX, INC. (PULM) reported Operating Expenses of $1.05 million for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-09-17
- PULMATRIX, INC. operating expenses for the quarter ending 2026-06-30 was $1.05M, a 32.43% decline year-over-year.
- PULMATRIX, INC. operating expenses for the quarter ending 2026-03-31 was $1.29M, a 30.05% decline year-over-year.
- PULMATRIX, INC. operating expenses for the quarter ending 2025-12-31 was $908.00K, a 53.55% decline year-over-year.
- PULMATRIX, INC. operating expenses for the quarter ending 2025-09-30 was $866.00K, a 71.35% decline year-over-year.
- PULMATRIX, INC. operating expenses for fiscal 2023 was $22.04M, a 11.91% decline from fiscal 2022.
- PULMATRIX, INC. operating expenses for fiscal 2022 was $25.02M, a 1.26% decline from fiscal 2021.
- PULMATRIX, INC. operating expenses for fiscal 2021 was $25.34M, a 12.62% increase from fiscal 2020.
- PULMATRIX, INC. operating expenses for fiscal 2020 was $22.50M, a 21.35% decline from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.05M S-4/A · filed 2026-09-17 | $2.34M S-4/A · filed 2026-09-17 | $3.25M derived: sum of 3 quarters · filed 2026-09-17 | $4.11M derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2026-03-31 | $1.29M S-4/A · filed 2026-08-03 | $2.20M derived: sum of 2 quarters · filed 2026-09-17 | $3.07M derived: sum of 3 quarters · filed 2026-09-17 | $4.61M derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2025-12-31 | $908.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $1.77M derived: sum of 2 quarters · filed 2026-09-17 | $3.32M derived: sum of 3 quarters · filed 2026-09-17 | $5.17M S-4/A · filed 2026-09-17 | ||
| 2025-09-30 | $866.00K 10-Q · filed 2025-10-16 | $2.41M derived: sum of 2 quarters · filed 2026-09-17 | $4.26M 10-Q · filed 2025-10-16 | $6.22M derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2025-06-30 | $1.55M S-4/A · filed 2026-09-17 | $3.40M S-4/A · filed 2026-09-17 | $5.35M derived: sum of 3 quarters · filed 2026-09-17 | $8.37M derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2025-03-31 | $1.85M S-4/A · filed 2026-08-03 | $3.80M derived: sum of 2 quarters · filed 2026-09-17 | $6.83M derived: sum of 3 quarters · filed 2026-09-17 | $14.28M derived: sum of 4 quarters · filed 2026-09-17 | ||
| 2024-12-31 | $1.96M derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $4.98M derived: sum of 2 quarters · filed 2026-09-17 | $12.43M derived: sum of 3 quarters · filed 2026-09-17 | $17.57M S-4/A · filed 2026-09-17 | ||
| 2024-09-30 | $3.02M 10-Q · filed 2025-10-16 | $10.48M derived: sum of 2 quarters · filed 2025-10-16 | $15.61M 10-Q · filed 2025-10-16 | $20.04M derived: sum of 4 quarters · filed 2025-10-16 | ||
| 2024-06-30 | $7.45M 10-Q · filed 2025-08-06 | $12.59M 10-Q · filed 2025-08-06 | $17.02M derived: sum of 3 quarters · filed 2025-08-06 | $22.71M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $5.14M 10-Q · filed 2025-05-15 | $9.56M derived: sum of 2 quarters · filed 2025-05-15 | $15.26M derived: sum of 3 quarters · filed 2025-05-15 | $21.09M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $10.12M derived: sum of 2 quarters · filed 2025-03-21 | $15.95M derived: sum of 3 quarters · filed 2025-03-21 | $22.04M 10-K · filed 2025-03-21 | ||
| 2023-09-30 | $5.69M 10-Q · filed 2024-11-08 | $11.53M derived: sum of 2 quarters · filed 2024-11-08 | $17.61M 10-Q · filed 2024-11-08 | $23.64M derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $5.83M 10-Q · filed 2024-08-13 | $11.92M 10-Q · filed 2024-08-13 | $17.95M derived: sum of 3 quarters · filed 2024-08-13 | $24.92M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $6.08M 10-Q · filed 2024-05-10 | $12.12M derived: sum of 2 quarters · filed 2024-05-10 | $19.09M derived: sum of 3 quarters · filed 2024-05-10 | $24.98M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $13.01M derived: sum of 2 quarters · filed 2024-03-28 | $18.89M derived: sum of 3 quarters · filed 2024-03-28 | $25.02M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $6.97M 10-Q · filed 2023-11-09 | $12.86M derived: sum of 2 quarters · filed 2023-11-09 | $18.98M 10-Q · filed 2023-11-09 | $23.48M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $5.89M 10-Q · filed 2023-08-10 | $12.01M 10-Q · filed 2023-08-10 | $16.51M derived: sum of 3 quarters · filed 2023-08-10 | $25.77M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $6.12M 10-Q · filed 2023-05-12 | $10.62M derived: sum of 2 quarters · filed 2023-05-12 | $19.88M derived: sum of 3 quarters · filed 2023-05-12 | $25.98M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $13.76M derived: sum of 2 quarters · filed 2023-03-30 | $19.86M derived: sum of 3 quarters · filed 2023-03-30 | $25.34M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $9.26M 10-Q · filed 2022-11-10 | $15.36M derived: sum of 2 quarters · filed 2022-11-10 | $20.84M 10-Q · filed 2022-11-10 | $25.51M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $6.10M 10-Q · filed 2022-08-10 | $11.58M 10-Q · filed 2022-08-10 | $16.25M derived: sum of 3 quarters · filed 2022-08-10 | $21.90M derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $5.47M 10-Q · filed 2022-05-12 | $10.15M derived: sum of 2 quarters · filed 2022-05-12 | $15.80M derived: sum of 3 quarters · filed 2022-05-12 | $20.47M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $10.32M derived: sum of 2 quarters · filed 2022-03-29 | $15.00M derived: sum of 3 quarters · filed 2022-03-29 | $22.50M 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $5.65M 10-Q · filed 2021-11-10 | $10.32M derived: sum of 2 quarters · filed 2021-11-10 | $17.82M 10-Q · filed 2021-11-10 | $23.62M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $4.67M 10-Q · filed 2021-08-10 | $12.17M 10-Q · filed 2021-08-10 | $17.97M derived: sum of 3 quarters · filed 2021-08-10 | $23.05M derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | $7.50M 10-Q · filed 2021-05-11 | $13.30M derived: sum of 2 quarters · filed 2021-05-11 | $18.38M derived: sum of 3 quarters · filed 2021-05-11 | $31.14M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $10.88M derived: sum of 2 quarters · filed 2021-03-23 | $23.64M derived: sum of 3 quarters · filed 2021-03-23 | $28.60M 10-K · filed 2021-03-23 | ||
| 2019-09-30 | $5.08M 10-Q · filed 2020-11-12 | $17.85M derived: sum of 2 quarters · filed 2020-11-12 | $22.80M 10-Q · filed 2020-11-12 | $28.07M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $12.77M 10-Q · filed 2020-08-07 | $17.72M 10-Q · filed 2020-08-07 | $22.99M derived: sum of 3 quarters · filed 2020-08-07 | $27.82M derived: sum of 4 quarters · filed 2020-08-07 | ||
| 2019-03-31 | $4.96M 10-Q · filed 2020-05-14 | $10.22M derived: sum of 2 quarters · filed 2020-05-14 | $15.05M derived: sum of 3 quarters · filed 2020-05-14 | $21.18M derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $5.27M 10-Q · filed 2019-05-15 | $10.09M derived: sum of 2 quarters · filed 2019-11-01 | $16.22M derived: sum of 3 quarters · filed 2019-11-01 | $20.55M 10-K · filed 2020-03-26 | $20.48M 10-K · filed 2019-02-19 | |
| 2018-09-30 | $4.83M 10-Q · filed 2019-11-01 | $10.95M derived: sum of 2 quarters · filed 2019-11-01 | $16.22M 10-Q · filed 2019-11-01 | $20.65M derived: sum of 4 quarters · filed 2019-11-01 | ||
| 2018-06-30 | $6.13M 10-Q · filed 2019-08-05 | $11.39M 10-Q · filed 2019-08-05 | $15.82M derived: sum of 3 quarters · filed 2019-08-05 | $20.46M derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2018-03-31 | $5.27M 10-Q · filed 2018-05-11 | $9.70M derived: sum of 2 quarters · filed 2019-02-19 | $14.34M derived: sum of 3 quarters · filed 2019-02-19 | $19.76M derived: sum of 4 quarters · filed 2019-02-19 | ||
| 2017-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $9.07M derived: sum of 2 quarters · filed 2019-02-19 | $14.50M derived: sum of 3 quarters · filed 2019-02-19 | $17.81M 10-K · filed 2019-02-19 | ||
| 2017-09-30 | $4.64M 10-Q · filed 2018-11-14 | $10.07M derived: sum of 2 quarters · filed 2018-11-14 | $13.38M 10-Q · filed 2018-11-14 | $20.95M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $5.43M 10-Q · filed 2018-08-03 | $8.74M 10-Q · filed 2018-08-03 | $16.32M derived: sum of 3 quarters · filed 2018-08-03 | $19.37M derived: sum of 4 quarters · filed 2018-08-03 | ||
| 2017-03-31 | $3.31M 10-Q · filed 2018-05-11 | $10.89M derived: sum of 2 quarters · filed 2018-05-11 | $13.94M derived: sum of 3 quarters · filed 2018-05-11 | $23.17M derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2016-12-31 | $7.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $10.63M derived: sum of 2 quarters · filed 2018-03-13 | $19.86M derived: sum of 3 quarters · filed 2018-03-13 | $25.70M 10-K · filed 2018-03-13 | ||
| 2016-09-30 | $3.06M 10-Q · filed 2017-11-09 | $12.29M derived: sum of 2 quarters · filed 2017-11-09 | $18.13M 10-Q · filed 2017-11-09 | $22.70M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $9.23M 10-Q · filed 2017-08-04 | $15.07M 10-Q · filed 2017-08-04 | $19.64M derived: sum of 3 quarters · filed 2017-08-04 | $24.95M derived: sum of 4 quarters · filed 2017-08-04 | ||
| 2016-03-31 | $5.84M 10-Q · filed 2017-05-05 | $10.41M derived: sum of 2 quarters · filed 2017-05-05 | $15.72M derived: sum of 3 quarters · filed 2017-05-05 | $27.21M derived: sum of 4 quarters · filed 2017-05-05 | ||
| 2015-12-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $9.88M derived: sum of 2 quarters · filed 2017-03-10 | $21.37M derived: sum of 3 quarters · filed 2017-03-10 | $24.22M 10-K · filed 2017-03-10 | ||
| 2015-09-30 | $5.31M 10-Q · filed 2016-11-04 | $16.80M derived: sum of 2 quarters · filed 2016-11-04 | $19.65M 10-Q · filed 2016-11-04 | $21.37M derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-06-30 | $11.49M 10-Q · filed 2016-08-04 | $14.34M 10-Q · filed 2016-08-04 | $16.06M derived: sum of 3 quarters · filed 2016-08-04 | $18.68M derived: sum of 4 quarters · filed 2016-08-04 | ||
| 2015-03-31 | $2.85M 10-Q · filed 2016-05-05 | $4.57M derived: sum of 2 quarters · filed 2016-05-05 | $7.19M derived: sum of 3 quarters · filed 2016-05-05 | $6.71M 10-K · filed 2015-06-10 | ||
| 2014-12-31 | $1.72M 10-Q · filed 2015-02-13 | $4.34M derived: sum of 2 quarters · filed 2015-11-12 | $5.15M 10-Q · filed 2015-02-13 | $9.43M 10-K · filed 2016-03-10 | ||
| 2014-09-30 | $2.62M 10-Q · filed 2015-11-12 | $1.72M 10-Q · filed 2014-11-13 | $3.43M 10-Q · filed 2014-11-13 | $7.49M 10-Q · filed 2015-11-12 | $6.72M derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | $2.45M 10-Q · filed 2015-08-14 | $1.72M 10-Q · filed 2014-08-14 | $4.87M 10-Q · filed 2015-08-14 | $4.10M derived: sum of 3 quarters · filed 2015-08-14 | $5.09M derived: sum of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | $989.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $1.65M derived: sum of 2 quarters · filed 2015-06-10 | $2.64M derived: sum of 3 quarters · filed 2015-06-10 | $3.12M 10-K · filed 2015-06-10 | ||
| 2013-12-31 | $658.00K 10-Q · filed 2015-02-13 | $1.65M derived: sum of 2 quarters · filed 2015-02-13 | $2.13M 10-Q · filed 2015-02-13 | |||
| 2013-09-30 | $994.00K 10-Q · filed 2014-11-13 | $1.47M 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | $477.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |